A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS

Z., Ying; X., Xiang; Y., Song; N., Ding; Y., Lin; W., Zheng; X., Wang; N., Lin; M., Tu; Y., Xie; C., Zhang; W., Liu; L., Deng; Y., Liu; Y., Yue; X., Yu; H., Liu; P., Duan; F., Chen; X., Wu; X.F., Huang; L., Jones; X., Kang; S., Chen; J., Zhu

doi:10.1002/hon.2438_131

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS

作者：Z., Ying; X., Xiang; Y., Song; N., Ding; Y., Lin; W., Zheng; X., Wang; N., Lin; M., Tu; Y., Xie; C., Zhang; W., Liu; L., Deng; Y., Liu; Y., Yue; X., Yu; H., Liu; P., Duan; F., Chen; X., Wu; X.F., Huang; L., Jones; X., Kang; S., Chen; J., Zhu

来源：Hematological Oncology, 2017, 35: 262-262.

DOI：10.1002/hon.2438_131